Descriptions:
We entered the indian pharma industry in 2000 about 2 decades ago with a new vision, the vast window of multi-pronged growth plans for the advancement of “Conglomerate Endocard” with a strong execution strength and self-commitment to provide growth to every individual associated with the family. We are also committed to fulfil our social obligations as a responsible corporate to provide health benefits to every Indian through innovative, unique and new pharmaceutical moieties and combinations.